AHNAK2 has been shown to be a prognostic marker in papillary thyroid cancer, clear cell renal cell carcinoma (ccRCC), and lung adenocarcinoma (35–37). The gene discussed is AHNAK2; the disease is nonpapillary renal cell carcinoma.